✦ LIBER ✦

Changes in Chromogranin A Serum Levels During Endocrine Therapy in Metastatic Prostate Cancer Patients

✍ Scribed by Tetsuro Sasaki; Akira Komiya; Hiroyoshi Suzuki; Masaki Shimbo; Takeshi Ueda; Koichiro Akakura; Tomohiko Ichikawa

Book ID: 113608923
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 190 KB
Volume: 48
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2005.03.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of high chromogranin A serum l

Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinoma

✍ Marialuisa Appetecchia, Aurela Meçule… 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 236 KB

DISTRIBUTION OF HIGH CHROMOGRANIN A (CGA

DISTRIBUTION OF HIGH CHROMOGRANIN A (CGA) SERUM LEVELS IN PATIENTS WITH NON-METASTATIC AND METASTATIC PROSTATE ADENOCARCINOMA

✍ A. Sciarra; V. Gentile; S. Salciccia; A. Autran Gomez; A. Alfarone; L. Iannotta; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Pretreatment Serum Level of Neuron Speci

Pretreatment Serum Level of Neuron Specific Enolase (NSE) as a Prognostic Factor in Metastatic Prostate Cancer Patients Treated with Endocrine Therapy

✍ Naoto Kamiya; Koichiro Akakura; Hiroyoshi Suzuki; Shinzou Isshiki; Akira Komiya; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Pretreatment serum level of HER2/nue as

Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy

✍ TAKATSUGU OKEGAWA; MANAMI KINJO; KIKUO NUTAHARA; EIJI HIGASHIHARA 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

MP-17.09: Serum chromogranin A in bone m

MP-17.09: Serum chromogranin A in bone metastatic prostate cancer: comparison with prostatic specific antigen

✍ A. Bantis; A. Zissimopoulos; C. Kalaitzis; P. Sountoulides; S. Giannakopoulos; E 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Serum chromogranin A: Early detection of

Serum chromogranin A: Early detection of hormonal resistance in prostate cancer patients

✍ James T. Wu; Mark E. Astill; Grace H. Liu; Robert A. Stephenson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

We monitored both chromogranin A (CgA) and neuron specific enolase (NSE) in serial serum specimens from 14 patients with prostate cancer (CAP patients) showing resistance to hormonal treatment. Elevated serum CgA was detected in 10 out of these 14 patients (71%) during treatment, and an early appear